Log In
BCIQ
Print this Print this
 

daprodustat (GSK1278863)

Also known as: 1278863

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionOral small molecule hypoxia-inducible factor prolyl hydroxylase (HIF-PH; EGLN) inhibitor
Molecular Target Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) (EGLN)
Mechanism of ActionHypoxia-inducible factor prolyl hydroxylase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationAnemia
Indication DetailsTreat anemia; Treat anemia associated with chronic kidney disease (CKD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today